Viewing Study NCT03674567


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-27 @ 4:00 AM
Study NCT ID: NCT03674567
Status: COMPLETED
Last Update Posted: 2025-01-24
First Post: 2018-09-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Sponsor: RAPT Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module